A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial1,2,3,4

  1. Neal D Barnard,
  2. Joshua Cohen,
  3. David JA Jenkins,
  4. Gabrielle Turner-McGrievy,
  5. Lise Gloede,
  6. Amber Green, and
  7. Hope Ferdowsian
  • 1 From the Department of Medicine, George Washington University School of Medicine, Washington, DC (NDB, JC, and HF); the Physicians Committee for Responsible Medicine, Washington, DC (NDB, AG, and HF); the Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Canada (DJAJ); the Clinical Nutrition and Risk Factor Modification Center, St Michael's Hospital, Toronto, Canada (DJAJ); the Department of Nutrition, School of Public Health, University of North Carolina, Chapel Hill, NC (GT-M); and Nutrition Coaching, LLC, Arlington, VA (LG).

  • 2 Presented at the symposium, “Fifth International Congress on Vegetarian Nutrition,” held in Loma Linda, CA, March 4–6, 2008.

  • 3 Supported by the National Institute of Diabetes and Digestive and Kidney Diseases (grant R01 DK059362-01A2) and the Diabetes Action Research and Education Foundation.

  • 4 Address reprint requests and correspondence to ND Barnard, 5100 Wisconsin Avenue, Suite 400, Washington, DC 20016. E-mail: nbarnard{at}pcrm.org.

Abstract

Background: Low-fat vegetarian and vegan diets are associated with weight loss, increased insulin sensitivity, and improved cardiovascular health.

Objective: We compared the effects of a low-fat vegan diet and conventional diabetes diet recommendations on glycemia, weight, and plasma lipids.

Design: Free-living individuals with type 2 diabetes were randomly assigned to a low-fat vegan diet (n = 49) or a diet following 2003 American Diabetes Association guidelines (conventional, n = 50) for 74 wk. Glycated hemoglobin (Hb A1c) and plasma lipids were assessed at weeks 0, 11, 22, 35, 48, 61, and 74. Weight was measured at weeks 0, 22, and 74.

Results: Weight loss was significant within each diet group but not significantly different between groups (−4.4 kg in the vegan group and −3.0 kg in the conventional diet group, P = 0.25) and related significantly to Hb A1c changes (r = 0.50, P = 0.001). Hb A1c changes from baseline to 74 wk or last available values were −0.34 and −0.14 for vegan and conventional diets, respectively (P = 0.43). Hb A1c changes from baseline to last available value or last value before any medication adjustment were −0.40 and 0.01 for vegan and conventional diets, respectively (P = 0.03). In analyses before alterations in lipid-lowering medications, total cholesterol decreased by 20.4 and 6.8 mg/dL in the vegan and conventional diet groups, respectively (P = 0.01); LDL cholesterol decreased by 13.5 and 3.4 mg/dL in the vegan and conventional groups, respectively (P = 0.03).

Conclusions: Both diets were associated with sustained reductions in weight and plasma lipid concentrations. In an analysis controlling for medication changes, a low-fat vegan diet appeared to improve glycemia and plasma lipids more than did conventional diabetes diet recommendations. Whether the observed differences provide clinical benefit for the macro- or microvascular complications of diabetes remains to be established. This trial was registered at clinicaltrials.gov as NCT00276939.